DRTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Alpha Tau Medical Ltd (DRTS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and neutral trading sentiment suggest that this stock does not present a compelling opportunity right now. It is better to hold off on investing in this stock until stronger growth signals or catalysts emerge.
The MACD is negatively expanding, indicating bearish momentum. The RSI is neutral at 48.911, showing no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 7.202, with support at 6.753 and resistance at 7.651. Overall, the technical indicators are mixed, leaning slightly bearish.
NULL identified. There is no recent news, no significant hedge fund or insider trading activity, and no recent congress trading data.
The stock has shown a -2.95% regular market change and a -2.34% post-market change. Additionally, the company's financial performance remains weak, with no revenue and a negative net income of -11.69M in Q3 2025, despite some YoY improvements.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income of -11.69M (up 68.78% YoY), and an EPS of -0.14 (up 40% YoY). While there are improvements in net income and EPS, the company remains unprofitable with no revenue generation.
No analyst rating or price target data is provided, making it difficult to gauge Wall Street's view on the stock.
